article thumbnail

Intoxicating Hemp Swindle

Project CBD

There’s also THCP, THCO, HHC, and others that can’t be made from CBD starter material and thus are outside the legal definition of “hemp.” AB 45 also instated a definition of Total THC, adding all intoxicating cannabinoids to the sum not just Delta-9. If the Total THC in a given product exceeds the 0.3%

Hemp 233
article thumbnail

One Signature Could Remove Marijuana From Schedule I Tomorrow

Canna Law Blog

Yes, the DEA would need to do some light follow-up rulemaking—but that’s been done before , and the Office of Legal Counsel has already signed off on it. Such purposes must, however, ensure the availability of cannabis (not referenced specifically, but included in the definition of “drugs”) to patients for relief from pain and suffering.

Marijuana 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

NORML

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver.

article thumbnail

THCO is a Controlled Substance: DEA

Cannabis Life Network

The Drug Enforcement Administration (DEA) says Delta-8 and -9 THCO are controlled substances, even when derived from hemp. The DEA said that Delta-8 and -9 THCO “do not occur naturally in the cannabis plant and can only be obtained synthetically, and therefore do not fall under the definition of hemp.”

DEA 98
article thumbnail

NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling

NORML

Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. The post NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling appeared first on NORML.

Marijuana 284
article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine. .”

DEA 98
article thumbnail

The DEA Wants To Add The Following Compunds To Schedule 1

Cannabis Law Report

The DEA released a proposed rule change on January 14 to put an impenetrable-looking group of substances—4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT—into Schedule I. The DEA is accepting written and oral feedback on its proposed rule change until February 14. In response, the DEA raided their lab in 1994.

DEA 72